Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD
Open Access
- 1 January 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 149-159
Abstract
Aim: Alpha-1 antitrypsin deficiency is an autosomal co-dominant condition that predisposes individuals to early-onset emphysema. As with COPD, AATD-COPD is associated with pulmonary exacerbations, which impacts on overall mortality and quality of life. Though there is evidence that COPD is associated with a higher prevalence of cardiovascular disease and major adverse cardiovascular events (MACE), it is unclear if this is true for patients with AATD-COPD. Methods: Prevalence of cardiovascular disease was determined in two separate severe AATD cohorts: AlphaNet, USA and the Birmingham AATD registry, UK. All patients had preexisting lung disease. Cardiovascular disease was defined as presence of any of the following: heart failure, ischaemic heart disease, atrial fibrillation, stroke, and myocardial infarction. A Cox proportional hazards model was used to assess the impact of prior cardiovascular disease and frequent exacerbator phenotype on risk of future MACE. Results: Out of 3493 patients with severe AATD, 14.7% had prior cardiovascular disease, including stroke (2.3%), myocardial infarction (2.2%), and heart failure (2.5%). Frequent exacerbators were more likely to have preexisting cardiovascular disease compared with those with one or no exacerbations in the preceding year (63% vs 44.8%, p = 0.001). There was increased risk of future MACE in frequent exacerbators (HR 1.85, 95% CI 1.24 to 2.75), former and current smokers (HR 1.80, 95% CI 1.07 to 3.02, p = 0.026, and HR 4.04, 95% CI 1.44 to 11.32, p = 0.008, respectively), and those with prior cardiovascular disease (HR 3.81, 95% CI 2.60 to 5.58, p < 0.001). Conclusion: In severe AATD-COPD, MACE are associated with an increased exacerbation frequency, previous cardiovascular disease, and a history of smoking.Keywords
This publication has 54 references indexed in Scilit:
- Desmosine, a biomarker for COPD: old and in the wayEuropean Respiratory Journal, 2012
- Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary diseaseThorax, 2012
- Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiencyRespiratory Research, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular FillingNew England Journal of Medicine, 2010
- Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan CanadaAnnals of Epidemiology, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- 1-Antitrypsin deficiency * 4: Molecular pathophysiologyThorax, 2004
- BLOOD-FLOW, VENTILATION, AND GAS EXCHANGE IN THE LUNGThe Lancet, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958